• 1. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 2. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 3. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrazolopyridines

Recent Advances in the Study of Ethyl 4-bromopyrazolo[1,5-a]pyridine-3-carboxylate (CAS: 55899-29-1)

Ethyl 4-bromopyrazolo[1,5-a]pyridine-3-carboxylate (CAS: 55899-29-1) is a heterocyclic compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its versatile applications in drug discovery and development. Recent studies have focused on its role as a key intermediate in the synthesis of biologically active molecules, particularly in the development of kinase inhibitors and other therapeutic agents. This research brief aims to provide an overview of the latest findings related to this compound, highlighting its synthetic utility, biological activities, and potential clinical applications.

One of the most notable advancements in the study of Ethyl 4-bromopyrazolo[1,5-a]pyridine-3-carboxylate is its application in the synthesis of novel kinase inhibitors. Kinases play a critical role in cellular signaling pathways, and their dysregulation is associated with various diseases, including cancer and inflammatory disorders. Researchers have successfully utilized this compound as a building block to develop potent and selective kinase inhibitors, demonstrating its importance in medicinal chemistry. For instance, a recent study published in the Journal of Medicinal Chemistry reported the synthesis of a series of pyrazolo[1,5-a]pyridine derivatives, including Ethyl 4-bromopyrazolo[1,5-a]pyridine-3-carboxylate, which exhibited promising inhibitory activity against specific kinase targets.

In addition to its role in kinase inhibitor development, Ethyl 4-bromopyrazolo[1,5-a]pyridine-3-carboxylate has also been explored for its potential in other therapeutic areas. Recent research has investigated its use in the synthesis of antimicrobial and anti-inflammatory agents. A study published in Bioorganic & Medicinal Chemistry Letters highlighted the compound's utility in the design of new antimicrobial scaffolds, with several derivatives showing significant activity against resistant bacterial strains. These findings underscore the compound's versatility and its potential to address unmet medical needs in infectious diseases.

The synthetic methodologies for Ethyl 4-bromopyrazolo[1,5-a]pyridine-3-carboxylate have also seen significant improvements. Recent publications have described more efficient and scalable routes for its preparation, which are crucial for its widespread application in drug discovery. For example, a paper in Organic Process Research & Development detailed a novel catalytic process that enhances the yield and purity of the compound, making it more accessible for large-scale production. These advancements are expected to facilitate further research and development efforts involving this compound.

Despite the progress made, challenges remain in the optimization of Ethyl 4-bromopyrazolo[1,5-a]pyridine-3-carboxylate-based therapeutics. Issues such as bioavailability, metabolic stability, and off-target effects need to be addressed to fully realize its clinical potential. Ongoing research is focused on structural modifications and formulation strategies to overcome these limitations. Collaborative efforts between academic institutions and pharmaceutical companies are expected to drive innovation in this area, paving the way for the development of next-generation therapeutics.

In conclusion, Ethyl 4-bromopyrazolo[1,5-a]pyridine-3-carboxylate (CAS: 55899-29-1) continues to be a valuable compound in the field of chemical biology and medicinal chemistry. Its applications in kinase inhibitor development, antimicrobial agents, and other therapeutic areas highlight its broad utility. With ongoing advancements in synthetic methodologies and a deeper understanding of its biological activities, this compound holds great promise for future drug discovery efforts. Researchers and industry professionals are encouraged to explore its potential further, leveraging the latest scientific findings to develop innovative and effective treatments.

• 16205-44-0(Ethyl pyrazolo[1,5-a]pyridine-3-carboxylate)
• 1062368-71-1(Methyl 4-bromopyrazolo[1,5-a]pyridine-3-carboxylate)
• 51135-70-7(Ethyl 5-methylpyrazolo[1,5-A]pyridine-3-carboxylate)
• 885276-93-7(Ethyl 5-bromopyrazolo[1,5-A]pyridine-3-carboxylate)
• 1356144-48-3(4-Bromopyrazolo[1,5-a]pyridine-3-carboxylic acid)
• 55899-18-8(6-Methyl pyrazolo1,5-apyridine-3-carboxylic Acid ethyl ester)
• 1062368-70-0(Methyl 6-bromopyrazolo[1,5-A]pyridine-3-carboxylate)
• 1260770-97-5(Ethyl 5-(hydroxymethyl)pyrazolo[1,5-a]pyridine-3-carboxylate)
• 55899-17-7(ethyl 4-methylpyrazolo[1,5-a]pyridine-3-carboxylate)
• 1211596-19-8(6-Bromopyrazolo[1,5-a]pyridine-3-carboxylic acid)